Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Gene expression profile in patients' samples with recurrent and persistent squamous cell cancer of head and neck

Agnes N. Juhasz, Xiwei Wu, Maricela Covarrubias, Frank Yen, Stephen Shibata, Yun Yen

Clin Cancer Res (2006) 12 (19_Supplement): B23.

Published: 15 August 2014

View article titled, Gene expression profile in patients' samples with recurrent and persistent squamous cell cancer of head and neck

Journal Articles

A Phase I Study of a Combination of Yttrium-90–Labeled Anti–Carcinoembryonic Antigen (CEA) Antibody and Gemcitabine in Patients with CEA-Producing Advanced Malignancies

Stephen Shibata, Andrew Raubitschek, Lucille Leong, Marianna Koczywas, Lawrence Williams, Jiping Zhan, Jeffrey Y.C. Wong

Clin Cancer Res (2009) 15 (8): 2935–2941.

https://doi.org/10.1158/1078-0432.CCR-08-2213

Published: 15 April 2009

View article titled, A Phase I Study of a Combination of Yttrium-90–Labeled Anti–Carcinoembryonic Antigen (CEA) Antibody and Gemcitabine in Patients with CEA-Producing Advanced Malignancies

Journal Articles

Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

Clin Cancer Res (2007) 13 (4): 1232–1237.

https://doi.org/10.1158/1078-0432.CCR-06-1735

Published: 22 February 2007

View article titled, Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

Journal Articles

Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel: Lack of Neuroprotective Effect of Amifostine

Harry Openshaw, Karen Beamon, Timothy W. Synold, Jeff Longmate, Neal E. Slatkin, James H. Doroshow, Stephen Forman, Kim Margolin, Robert Morgan, Stephen Shibata, George Somlo

Clin Cancer Res (2004) 10 (2): 461–467.

https://doi.org/10.1158/1078-0432.CCR-0772-03

Published: 03 February 2004

View article titled, Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel: <subtitle>Lack of Neuroprotective Effect of Amifostine</subtitle>

Journal Articles

A Phase I Trial of ⁹⁰Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer

Jeffrey Y. C. Wong, Stephen Shibata, Lawrence E. Williams, Cheuk S. Kwok, An Liu, David Z. Chu, Dave M. Yamauchi, Sharon Wilczynski, David N. Ikle, Anna M. Wu, Paul J. Yazaki, John E. Shively, James H. Doroshow, Andrew A. Raubitschek

Clin Cancer Res (2003) 9 (16): 5842–5852.

Published: 15 December 2003

View article titled, A Phase I Trial of <sup>90</sup>Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer

Journal Articles

Phase I Trial of Intraperitoneal Docetaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: Dose-Limiting Toxicity and Pharmacokinetics

Robert J. Morgan, Jr., James H. Doroshow, Timothy Synold, Dean Lim, Stephen Shibata, Kim Margolin, Roderich Schwarz, Lucille Leong, George Somlo, Przemyslaw Twardowski, Yun Yen, Warren Chow, Paul Lin, Benjamin Paz, David Chu, Paul Frankel, Susan Stalter

Clin Cancer Res (2003) 9 (16): 5896–5901.

Published: 15 December 2003

View article titled, Phase I Trial of Intraperitoneal Docetaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: <subtitle>Dose-Limiting Toxicity and Pharmacokinetics</subtitle>

Journal Articles

Phase I Trial of 96-Hour Continuous Infusion of Dexrazoxane in Patients with Advanced Malignancies

Merry L. Tetef, Timothy W. Synold, Warren Chow, Lucille Leong, Kim Margolin, Robert Morgan, James Raschko, Stephen Shibata, George Somlo, Yun Yen, Susan Groshen, Kay Johnson, Heinz-Josef Lenz, David Gandara, James H. Doroshow

Clin Cancer Res (2001) 7 (6): 1569–1576.

Published: 01 June 2001

View article titled, Phase I Trial of 96-Hour Continuous Infusion of Dexrazoxane in Patients with Advanced Malignancies

Journal Articles

Pharmacokinetic and Pharmacodynamic Evaluation of the Glycinamide Ribonucleotide Formyltransferase Inhibitor AG2034

Howard L. McLeod, James Cassidy, Robert H. Powrie, David G. Priest, Mark A. Zorbas, Timothy W. Synold, Stephen Shibata, Darcy Spicer, Donald Bissett, Yazdi K. Pithavala, Mary A. Collier, Linda J. Paradiso, John D. Roberts

Clin Cancer Res (2000) 6 (7): 2677–2684.

Published: 01 July 2000

View article titled, Pharmacokinetic and Pharmacodynamic Evaluation of the Glycinamide Ribonucleotide Formyltransferase Inhibitor AG2034

NARROW

Gene expression profile in patients' samples with recurrent and persistent squamous cell cancer of head and neck

A Phase I Study of a Combination of Yttrium-90–Labeled Anti–Carcinoembryonic Antigen (CEA) Antibody and Gemcitabine in Patients with CEA-Producing Advanced Malignancies

Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel: Lack of Neuroprotective Effect of Amifostine

A Phase I Trial of ⁹⁰Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer

Phase I Trial of Intraperitoneal Docetaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: Dose-Limiting Toxicity and Pharmacokinetics

Phase I Trial of 96-Hour Continuous Infusion of Dexrazoxane in Patients with Advanced Malignancies

Pharmacokinetic and Pharmacodynamic Evaluation of the Glycinamide Ribonucleotide Formyltransferase Inhibitor AG2034

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only